Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report.

Saved in:
Bibliographic Details
Title: Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report.
Authors: Murakami, Satoshi1 (AUTHOR) satmurak@sis.seirei.or.jp, Yamagishi, Kazutaka2 (AUTHOR), Kitani, Akira3 (AUTHOR), Ueta, Toru4 (AUTHOR), Matsuura, Yasuaki1 (AUTHOR), Kubota, Toru1 (AUTHOR), Uezono, Yasuhito5 (AUTHOR)
Source: Journal of Palliative Medicine. Apr2026, Vol. 29 Issue 4, p557-561. 5p.
Database: Academic Search Ultimate
Description
ISSN:10966218
DOI:10.1177/10966218251385732